Evidence map›Paper›PMID 37069257›Full record

ArticleScientific reports2023

Value of handcrafted and deep radiomic features towards training robust machine learning classifiers for prediction of prostate cancer disease aggressiveness.

Ana Rodrigues, Nuno Rodrigues, João Santinha, Maria V Lisitskaya, Aycan Uysal, Celso Matos, Inês Domingues, Nickolas Papanikolaou

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Insights into radiomics: a comprehensive review for beginners.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Applications of artificial intelligence in urologic oncology.Investigative and clinical urology · 2024
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana RodriguesChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal. anacarolina.rodrigues@research.fchampalimaud.org.
Nuno RodriguesChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
João SantinhaChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
Maria V LisitskayaCand. of Sci. (Med.), Radiologist at Radiology Department with CT and MRI, Medical Research and Educational Center, Lomonosov Moscow State University, Moscow, Russia.
Aycan UysalGulhane Medical School, University of Health Sciences, Ankara, Turkey.
Celso MatosChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
Inês DominguesInstituto Politécnico de Coimbra, Instituto Superior de Engenharia, Rua Pedro Nunes-Quinta da Nora, 3030-199, Coimbra, Portugal.
Nickolas PapanikolaouChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a growing piece of evidence that artificial intelligence may be helpful in the entire prostate cancer disease continuum. However, building machine learning algorithms robust to inter- and intra-radiologist segmentation variability is still a challenge. With this goal in mind, several model training approaches were compared: removing unstable features according to the intraclass correlation coefficient (ICC); training independently with features extracted from each radiologist's mask; training with the feature average between both radiologists; extracting radiomic features from the intersection or union of masks; and creating a heterogeneous dataset by randomly selecting one of the radiologists' masks for each patient. The classifier trained with this last resampled dataset presented with the lowest generalization error, suggesting that training with heterogeneous data leads to the development of the most robust classifiers. On the contrary, removing features with low ICC resulted in the highest generalization error. The selected radiomics dataset, with the randomly chosen radiologists, was concatenated with deep features extracted from neural networks trained to segment the whole prostate. This new hybrid dataset was then used to train a classifier. The results revealed that, even though the hybrid classifier was less overfitted than the one trained with deep features, it still was unable to outperform the radiomics model.

Indexed as

Artificial IntelligenceProstatic NeoplasmsAlgorithmsHumansMachine LearningMale

Identifiers

PMID37069257
PMCPMC10110526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.